Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
William Valentine, Kirsi Norrbacka & Kristina Secnik Boye. (2022) Evaluating the Impact of Therapy on Quality of Life in Type 2 Diabetes: A Literature Review of Utilities Associated with Treatment-Related Attributes. Patient Related Outcome Measures 13, pages 97-111.
Read now
Read now
Kristina S. Boye, Louis S. Matza, Katie D. Stewart, Haylee Andrews, Timothy A. Howell, Adam Stefanski, Karen G. Malley, K. Jack Ishak & Laura Fernández Landó. (2022) Health state utilities associated with weight loss in type 2 diabetes and obesity. Journal of Medical Economics 25:1, pages 14-25.
Read now
Read now
Kristina S. Boye, Louis S. Matza, Katie D. Stewart, Jessica Jordan, Giovanni Biricolti, Silvia Del Santo, Magaly Perez-Nieves, Marco O. Federici, Raffaella Gentilella, Serena Losi & Kirsi Norrbacka. (2019) Patient preferences and health state utilities associated with dulaglutide and semaglutide injection devices among patients with type 2 diabetes in Italy. Journal of Medical Economics 22:8, pages 806-813.
Read now
Read now
Articles from other publishers (7)
Ayman A. Al Hayek & Mohamed A. Al Dawish. (2022) Evaluation of Patient-Reported Satisfaction and Clinical Efficacy of Once-Weekly Semaglutide in Patients with Type 2 Diabetes: An Ambispective Study. Advances in Therapy 39:4, pages 1582-1595.
Crossref
Crossref
Kristina S. Boye, Jessica B. Jordan, Raleigh E. Malik, Brooke M. Currie & Louis S. Matza. (2021) Patient Perceptions of and Preferences Between Characteristics of Injectable Diabetes Treatments. Diabetes Therapy 12:9, pages 2387-2403.
Crossref
Crossref
José Gerardo González-González, Alejandro Díaz González-Colmenero, Juan Manuel Millán-Alanís, Lyubov Lytvyn, Ricardo Cesar Solis, Reem A Mustafa, Suetonia C Palmer, Sheyu Li, Qiukui Hao, Neri Alejandro Alvarez-Villalobos, Per Olav Vandvik & René Rodríguez-Gutiérrez. (2021) Values, preferences and burden of treatment for the initiation of GLP-1 receptor agonists and SGLT-2 inhibitors in adult patients with type 2 diabetes: a systematic review. BMJ Open 11:7, pages e049130.
Crossref
Crossref
Louis S. Matza, Katelyn N. Cutts, Katie D. Stewart, Kirsi Norrbacka, Luis-Emilio García-Pérez & Kristina S. Boye. (2021) Health state utilities associated with treatment process for oral and injectable GLP-1 receptor agonists for type 2 diabetes. Quality of Life Research 30:7, pages 2033-2043.
Crossref
Crossref
Taixiong Chen, Li Zhou, Ke Wang, Xiao Ma, Haiya Wu, Xin Liu, Jingyu Tong, Bojing Cai & Qiuhe Ji. (2020) The Unmet Medical Needs of Current Injectable Antidiabetic Therapies in China: Patient and Health Care Professional Perspectives. Clinical Therapeutics 42:8, pages 1549-1563.
Crossref
Crossref
Louis S. Matza, Kristina S. Boye, Katie D. Stewart, Karin S. Coyne, Paula K. Wullenweber, Katelyn N. Cutts, Jessica B. Jordan, Qianqian Wang, Maria Yu, Brooke M. Currie, Karen G. Malley, K. Jack Ishak, Ryan T. Hietpas & Luis‐Emilio García‐Pérez. (2019) Assessing patient PREFERence between the dulaglutide pen and the semaglutide pen: A crossover study (PREFER). Diabetes, Obesity and Metabolism 22:3, pages 355-364.
Crossref
Crossref
Louis S. Matza, Beatrice Osumili, Katie D. Stewart, Magaly Perez-Nieves, Jessica Jordan, Giovanni Biricolti, Ester Romoli, Serena Losi, Silvia Del Santo, Erik Spaepen, Gordon Parola, Hayley Karn & Kristina S. Boye. (2019) Patient Preferences and Health State Utilities Associated with Mealtime Insulin Concentrations Among Patients with Diabetes in Italy. Diabetes Therapy 11:1, pages 319-330.
Crossref
Crossref